Drug-coated balloon in the treatment of coronary bifurcation lesions: A hope or hype?
Dash D, Mody R, Ahmed N, Malan SR, Mody B.
Indian Heart J. 2022 Nov-Dec;74(6):450-457. doi: 10.1016/j.ihj.2022.10.193. Epub 2022 Nov 5.
Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea.
Kwon O, Ahn JM, Kang DY, Kang SH, Lee PH, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Park DW, Park SJ.
Korean J Intern Med. 2018 Sep;33(5):922-932. doi: 10.3904/kjim.2016.368. Epub 2017 Nov 7.
Application of Drug-Coated Balloons in Complex High Risk and Indicated Percutaneous Coronary Interventions.
Somsen YBO, Rissanen TT, Hoek R, Ris TH, Stuijfzand WJ, Nap A, Kleijn SA, Henriques JP, de Winter RW, Knaapen P.
Catheter Cardiovasc Interv. 2025 Feb;105(2):494-516. doi: 10.1002/ccd.31316. Epub 2024 Dec 11.
Outcomes of biodegradable polymer sirolimus-eluting PROLIM stent in patients with coronary artery disease. Results of 12-month follow-up of prospective registry.
Roleder T, Smolka G, Podolecka E, Chudek J, Dworowy S, Żelazowska K, Wojakowski W, Ochała A.
Kardiol Pol. 2016;74(5):411-7. doi: 10.5603/KP.a2015.0208. Epub 2015 Oct 27.
Riku S, Suzuki S, Yokoi T, Sakaguchi T, Yamamoto T, Jinno Y, Tanaka A, Ishii H, Inden Y, Murohara T.
Nagoya J Med Sci. 2022 May;84(2):352-365. doi: 10.18999/nagjms.84.2.352.
Clinical outcomes of a dedicated bifurcation stent system.
Sivalingam J, Mazhar MW, Chaddad RA, Fouladvand F, Cortese B.
Cardiovasc Revasc Med. 2024 Feb;59:21-26. doi: 10.1016/j.carrev.2023.08.015. Epub 2023 Aug 31.
Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study.
Asano T, Kogame N, Onuma Y, Modolo R, Chichareon P, Lefèvre T, Legutko J, Digne F, Morel MA, Serruys PW, Gil RJ.
EuroIntervention. 2020 Oct 23;16(8):654-662. doi: 10.4244/EIJ-D-19-00361.
Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry.
Tröbs M, Achenbach S, Nef HM, Gori T, Naber C, Neumann T, Richardt G, Schmermund A, Wöhrle J, Zahn R, Hamm CW; GABI-R Study Group.
Catheter Cardiovasc Interv. 2021 Oct;98(4):E564-E570. doi: 10.1002/ccd.29831. Epub 2021 Jun 17.
Treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds.
Capranzano P, Gargiulo G, Capodanno D, Longo G, Tamburino C, Ohno Y, Attizzani GF, La Manna A, Di Salvo M, Francaviglia B, Grasso C, Sgroi C, Tamburino C.
Minerva Cardioangiol. 2014 Jun;62(3):229-34.
Unprotected left main coronary artery bifurcation stenosis: impact of plaque debulking prior to single sirolimus-eluting stent implantation.
Tanaka N, Terashima M, Kinoshita Y, Kimura M, Nasu K, Ehara M, Tsuchikane E, Matsubara T, Asakura Y, Katoh O, Suzuki T.
J Invasive Cardiol. 2008 Oct;20(10):505-10.
